流式液相蛋白定量技术测定生物医用材料产品体液免疫评价中免疫球蛋白含量

      Determination of Immunoglobulin Content in Humoral Immunity Evaluation of Biomedical Material Products by Cytometric Beads Array

      • 摘要: 该研究采用流式液相蛋白定量技术测定生物医用材料产品体液免疫评价中免疫球蛋白含量。选用牛源异种脱细胞真皮基质为试验样品,按照高、中、低剂量组植入至Balb/C小鼠皮下至4周。4周后用流式液相多重蛋白定量技术测定IgG1、IgG2a、IgG2b、IgG3、IgA、IgM,将试验组与对照组的数据进行统计学分析。结果表明,与阴性对照组相比,阳性对照组中IgG3、IgA含量未见明显差异,而IgG1、IgG2a、IgG2b、IgM含量显著性高于阴性对照组;样品组高、中、低剂量组均未见明显差异。结果表明该方法适用于生物医用材料产品体液免疫评价中免疫球蛋白含量分析。

         

        Abstract: In this study, cytometric beads array(CBA) was used to determine the immunoglobulin content in humoral immunity evaluation of biomedical materials. The bovine-derived acellular dermal matrix was selected as a test sample and implanted into Balb/C mice subcutaneously to 4 weeks according to the high, medium and low dose groups. Four weeks later, IgG1, IgG2a, IgG2b, IgG3, IgA, and IgM were measured by CBA. The data of the test group and the control group were analyzed statistically. The results showed that compared with the negative control group, there was no significant difference in the IgG3, IgA content in the positive control group, while the IgG1, IgG2a, IgG2b, and IgM contents were significantly higher than the negative control group; no significant differences were seen in the sample groups. The results show that the method is suitable for analysis of immunoglobulin content in humoral immunity evaluation of biomedical materials.

         

      /

      返回文章
      返回